These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36202224)

  • 1. Hypoxia promotes the expression of Von Willebrand factor in breast cancer cells by up-regulating the transcription factor YY1 and down-regulating the hsa-miR-424.
    Tao Q; Lu Y; Qi Y; Yu D; Gu J; Zhu Y; Shi C; Liang X
    Eur J Pharmacol; 2022 Nov; 934():175308. PubMed ID: 36202224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer cells-derived Von Willebrand Factor promotes VEGF-A-related angiogenesis through PI3K/Akt-miR-205-5p signaling pathway.
    Tao Q; Qi Y; Gu J; Yu D; Lu Y; Liu J; Liang X
    Toxicol Appl Pharmacol; 2022 Apr; 440():115927. PubMed ID: 35192807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia results in upregulation and de novo activation of von Willebrand factor expression in lung endothelial cells.
    Mojiri A; Nakhaii-Nejad M; Phan WL; Kulak S; Radziwon-Balicka A; Jurasz P; Michelakis E; Jahroudi N
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1329-38. PubMed ID: 23580145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cells of different organs exhibit heterogeneity in von Willebrand factor expression in response to hypoxia.
    Mojiri A; Alavi P; Lorenzana Carrillo MA; Nakhaei-Nejad M; Sergi CM; Thebaud B; Aird WC; Jahroudi N
    Atherosclerosis; 2019 Mar; 282():1-10. PubMed ID: 30665023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration.
    Dhami SPS; Patmore S; Comerford C; Byrne CM; Cavanagh B; Castle J; Kirwan CC; Kenny M; Schoen I; O'Donnell JS; O'Sullivan JM
    J Thromb Haemost; 2022 Oct; 20(10):2350-2365. PubMed ID: 35722954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Targeting of Angipoietin-1 and von Willebrand Factor by microRNA-671-5p Attenuates Liver Angiogenesis and Fibrosis.
    Yang L; Yue W; Zhang H; Zhang Z; Xue R; Dong C; Liu F; Chang N; Yang L; Li L
    Hepatol Commun; 2022 Jun; 6(6):1425-1442. PubMed ID: 35014213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis.
    Wang AM; Huang TT; Hsu KW; Huang KH; Fang WL; Yang MH; Lo SS; Chi CW; Lin JJ; Yeh TS
    Oncotarget; 2014 Jul; 5(13):5002-16. PubMed ID: 24970812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
    Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
    Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
    Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
    Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice.
    Nassiri M; Liu J; Kulak S; Uwiera RR; Aird WC; Ballermann BJ; Jahroudi N
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1423-9. PubMed ID: 20431063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional factor Yin Yang 1 facilitates the stemness of ovarian cancer via suppressing miR-99a activity through enhancing its deacetylation level.
    Qian S; Wang W; Li M
    Biomed Pharmacother; 2020 Jun; 126():110085. PubMed ID: 32199224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.
    Liu H; Qiu Y; Pei X; Chitteti R; Steiner R; Zhang S; Jin ZG
    Sci Rep; 2020 Nov; 10(1):20493. PubMed ID: 33235311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIF-1/SNHG1/miR-199a-3p/TFAM axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancer.
    Zuo Y; Qu C; Tian Y; Wen Y; Xia S; Ma M
    Biofactors; 2021 May; 47(3):444-460. PubMed ID: 34003544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.
    Lieberthal JG; Kaminsky M; Parkhurst CN; Tanese N
    Breast Cancer Res; 2009; 11(3):R42. PubMed ID: 19566924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice.
    Kleinschmidt AM; Nassiri M; Stitt MS; Wasserloos K; Watkins SC; Pitt BR; Jahroudi N
    J Biol Chem; 2008 Feb; 283(5):2741-50. PubMed ID: 18048367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lncRNA-ATB/miR-651-3p/Yin Yang 1 pathway on trophoblast-endothelial cell interaction networks.
    Yin Y; Zhang J; Yu H; Liu M; Zheng X; Zhou R
    J Cell Mol Med; 2021 Jun; 25(12):5391-5403. PubMed ID: 33942988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis.
    Zanetta L; Marcus SG; Vasile J; Dobryansky M; Cohen H; Eng K; Shamamian P; Mignatti P
    Int J Cancer; 2000 Jan; 85(2):281-8. PubMed ID: 10629090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.
    Sun X; Huang T; Zhang C; Zhang S; Wang Y; Zhang Q; Liu Z
    Cell Cycle; 2019 Aug; 18(16):1908-1924. PubMed ID: 31213129
    [No Abstract]   [Full Text] [Related]  

  • 20. Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy.
    Infante T; Mancini FP; Lanza A; Soricelli A; de Nigris F; Napoli C
    Biochim Biophys Acta; 2015 May; 1853(5):975-86. PubMed ID: 25644713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.